Article Sidebar

Submitted
Mar 25, 2021
Published
Mar 25, 2021
Download
PDF
Statistic
Read Counter : 101 Download : 55

Main Article Content

Abstract

Background


Malaria is caused by parasite plasmodium species which is transmitted via the bite of infected mosquitoes, the key approach to treat malaria include prompt and effective treatment with Artemisinin based combination therapy. The search for additional antimalarial from plant extracts and their combination with Artemisinin derivatives must continue to help in effective treatment of the disease.


Aim


To evaluate the antimalarial efficacy of Nyctanthes arbor-tristis (NAT) and its effect on combination with Artesunate. 


Materials and Methods


The study was done in theDepartment of Molecular Bioprospection, CSIR-CIMAP, Lucknow, Uttar Pradesh, India. Leaves of Nyctanthes arbor tristis (NAT) were chosen, dried, grounded and extracted with solvent of variable polarity. The bioactivity of NAT leaf extracts was carried out through Plasmodium berghei induced malaria in albino swiss mice animal model. The two independent experiments gave us the result to plan the third experiment on combination therapy. From the first experiment IC50 of Artesunate was derived and from the second experiment the Methanol 80% extract of NAT was found to be indicative of the plant bioactive. The experiment involving the combination therapy was taken up by combining 20mg/kg of Artesunate with 250mg/Kg and 500mg/Kg of Methanol 80% extract of NAT.


Results


Our study showed that by combining Methanol 80% extract of NAT with sub effective dose of Artesunate results in improvement of mean survival time, parasitaemia and haemoglobin levels.


Conclusion


Our experiment helped us to conclude that NAT leaves can be used as a lead for combination therapy. However, further detailed experiments related to the safety and pharmacokinetics of combination need to be considered.

Keywords

Artesunate Malaria Nyctanthes arbor-tristis Plasmodium

Article Details

How to Cite
Ashwini Kumar Singh, Aniraban Pal, & Hemant Kumar Dutt. (2021). Antimalarial efficacy of Nyctanthes arbor-tristis and its effect on combination with Artesunate in Plasmodium berghei K173 induced mice model. International Journal of Research in Pharmacology & Pharmacotherapeutics, 8(1), 1-9. https://doi.org/10.61096/ijrpp.v8.iss1.2019.1-9
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Buffet PA, Safeukui I , Deplaine G, Brousse V, Prendki V, Thellier M, Turner GD, Mercereau-Puijalon O.
  2. [2]. WHO Fact sheet [Internet]. 2016 [cited 2018 Dec 26].
  3. Available from: http://www.who.int/mediacentre/factsheets/fs094/en/
  4. [3]. White NJ. Plasmodium knowlesi: the fifth human malaria parasite. Clin. Infect. Dis. 46, 2008, 172–173.
  5. [4]. WHO Fact Sheet: World Malaria Report [Internet]. 2015 Dec [cited 2018 Dec 26]. Available from: http://www.who.int/malaria/media/world-malaria-report-2015/en/
  6. [5]. National Drug Policy on Malaria [Internet]. 2013 [cited 2018 Dec 26]. Available from: http://nvbdcp.gov.in/Doc/National-Drug-Policy-2013.pdf
  7. [6]. Rani C, Chawla S, Mangal M, Mangal AK, Kajla S and Dhawan AK: Nyctanthes arbor-tristis Linn. (Night Jasmine): A sacred ornamental plant with immense medicinal potentials. Indian Journal of Traditional Knowledge. 11(3), 2012, 427-435.
  8. [7]. Das S, Sasmal D, Basu SP. Antispasmodic and antihelmintic activity of Nyctanthes arbor-tristis Linn. International Journal of Pharmaceutical Sciences and Research 1, 2010, 51-55.
  9. [8]. Vats M, Sharma N, Sardana S. Antimicrobial activity of stem bark extracts of Nyctanthes arbor-tristis Linn. (Oleaceae) International Journal of Pharmacognosy and Phytochemical Research 1, 2009, 12-14.
  10. [9]. Poddar A, Banerjee A, Ghanta S, Chattopadhyay S. In-vivo efficacy of calceolarioside A against experimental visceral leishmaniasis. Planta Medica. 74(5), 2008, 503-508.
  11. [10]. Gupta P, Bajaj SK, Chandra K, Singh KL, Tandon JS. Antiviral profile of Nyctanthes arbor-tristis against encephalitis causing viruses. Indian Journal of Experimental Biology 43, 2005, 1156-1160.
  12. [11]. Karnik SR, Tathed PS, Antarkar DS, Gidse CS, Vaidya RA, et al. Antimalarial activity and clinical safety of traditionally used Nyctanthes arbortristis Linn. Indian Journal of Traditional Knowledge 7, 2008, 330–334.
  13. [12]. CPCSEA. Guidelines for laboratory animal facility. Ind. J. Pharmacol. 35, 2003, 257-274.
  14. [13]. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 193, 1976, 673-5.
  15. [14]. Kalra B S, Chawla S, Gupta P, Valecha N. Screening of antimalarial drugs: An overview. Indian J Pharmacol 38, 2006, 5-12.
  16. [15]. Kumari P, Sahal D, Jain SK, and Chauhan VS. Bioactivity Guided Fractionation of Leaves Extract of Nyctanthes arbor tristis (Harshringar) against P falciparum. PLoS One. 7(12), 2012, e51714.
  17. [16]. Bhattacharya S, Ghosh AK Phytosomes: The Emerging Technology for Enhancement of Bioavailability of Botanicals and Nutraceuticals. The Internet Journal of Aesthetic and Antiaging Medicine 2, 2009, 1.
  18. [17]. Badam L, Deolankar RP, Rojatkar SR, Nagsampgi BA, Wagh UV. In vitro antimalarial activity of medicinal plants of India. Indian J Med Res. 87, 1988, 379-383.
  19. [18]. Misra P, Pal NL, Guru PY, Katiyar JC, Tandon JS. Antimalarial activity of traditional plants against erythrocytic stages of Plasmodium berghei. International Journal of Pharmacognosy. 29, 1991, 19-23.
  20. [19]. Agrawal J, Shanker K, Chanda D, Pal A, Nyctanthes arbor-tristis positively affects immunopathology of malaria-infected mice prolonging its survival. Parasitol Res. 1127, 2013, 2601–9.
  21. [20]. Godse CS. An Exploration and Putative Interventional Effect of Nyctanthes arbor-tristis (Parijat) in Malaria: Clinical, Metabolic, Parasite and Immune Changes. Ph.D. dissertation, Applied Biology, University of Mumbai; 2004.
  22. [21]. Desai SV, Dhumal AS, Chauhan PS.Literature review on Nyctanthes arbor-tristis. International Journal of Pharmacy & Technology, 8(1), 2016, 3611-3628.